ArticleCancer letters2012

Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.

Janeen H Trembley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.